Efficacy of biological inhibitors in three-dimensional culture models of oral squamous cell carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Despite advancements in therapeutic approaches, radiotherapy and cisplatin-based chemotherapy remain primary noninvasive treatments for patients with oral squamous cell carcinoma (OSCC). Moreover, the 5-year survival rate for patients with OSCC has remained almost unchanged for several decades, and many side effects of chemotherapy still exist. In this study, three-dimensional (3D) models of OSCC were established using fibroblasts, and the efficacy of various biological inhibitors was evaluated. A culture of epithelial cells with two types of fibroblasts (hTERT-hNOFs and cancer-associated fibroblasts) within a type I collagen matrix resulted in the formation of a continuous layer of tightly packed cells compared to models without fibroblasts. Furthermore, the effects of biological chemicals, including Y27632, latrunculin A, and verteporfin, on these models were investigated. The stratified formation of the epithelial layer and invasion in OSCC 3D-culture models were effectively inhibited by verteporfin, whereas invasion was weakly inhibited by Y27632 and latrunculin. Collectively, the developed OSCC 3D-culture models established with fibroblasts demonstrated the potential for drug screening, with verteporfin showing promising efficacy.
Abstract
Despite advancements in therapeutic approaches, radiotherapy and cisplatin-based chemotherapy remain primary noninvasive treatments for patients with oral squamous cell carcinoma (OSCC). Moreover, the 5-year survival rate for patients with OSCC has remained almost unchanged for several decades, and many side effects of chemotherapy still exist. In this study, three-dimensional (3D) models of OSCC were established using fibroblasts, and the efficacy of various biological inhibitors was evaluated. A culture of epithelial cells with two types of fibroblasts (hTERT-hNOFs and cancer-associated fibroblasts) within a type I collagen matrix resulted in the formation of a continuous layer of tightly packed cells compared to models without fibroblasts. Furthermore, the effects of biological chemicals, including Y27632, latrunculin A, and verteporfin, on these models were investigated. The stratified formation of the epithelial layer and invasion in OSCC 3D-culture models were effectively inhibited by verteporfin, whereas invasion was weakly inhibited by Y27632 and latrunculin. Collectively, the developed OSCC 3D-culture models established with fibroblasts demonstrated the potential for drug screening, with verteporfin showing promising efficacy.
참고문헌 (28)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)[DOI]
- Marcu L, "Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer--a review of their cooperation", Acta Oncol, 42, pp.315~325 (2003)[DOI]
- Kiyota N, "Weekly cisplatin plus radiation for postoperative head and neck cancer(JCOG1008) : a multicenter, noninferiority, phase II", III randomized controlled trial, 2022, pp.40, 1980~1990
- da Silva SD, "Recurrent oral cancer : current and emerging therapeutic approaches", Front Pharmacol, 3, pp.149~ (2012)[DOI]
- Badwelan M, "Oral squamous cell carcinoma and concomitant primary tumors, what do we know? A review of the literature", Curr Oncol, 30, pp.3721~3734 (2023)[DOI]
- Jerjes W, "Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients", Head Neck Oncol, 2, pp.9~ (2010)[DOI]
- Kapałczyńska M, "2D and 3D cell cultures-a comparison of different types of cancer cell cultures", Arch Med Sci, 14, pp.910~919 (2018)[DOI]
- Van Norman GA, "Limitations of animal studies for predicting toxicity in clinical trials : is it time to rethink our current approach?", JACC Basic Transl Sci, 4, pp.845~854 (2019)[DOI]
- Almagro J, "Tissue architecture in tumor initiation and progression", Trends Cancer, 8, pp.494~505 (2022)[DOI]
- Chitturi Suryaprakash RT, "A novel preclinical in vitro 3D model of oral carcinogenesis for biomarker discovery and drug testing", Int J Mol Sci, 24, pp.4096~ (2023)[DOI]
- Kwon JS, "Cytotoxicity evaluation of zinc oxide-eugenol and non-eugenol cements using different fibroblast cell lines", Acta Odontol Scand, 72, pp.64~70 (2014)[DOI]
- Illeperuma RP, "Areca nut exposure increases secretion of tumor-promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytes", Int J Cancer, 137, pp.2545~2557 (2015)[DOI]
- Kim EK, "CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma", PLoS One, 13, pp.e0188847~ (2018)[DOI]
- Kim DK, "Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts", PLoS One, 14, pp.e0214553~ (2019)[DOI]
- Lee EJ, "Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells", Exp Mol Med, 37, pp.379~390 (2005)[DOI]
- Kitamura N, "Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma", Int J Mol Sci, 22, pp.240~ (2020)[DOI]
- Miserocchi G, "Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas", Cancer Biol Med, 18, pp.502~516 (2021)[DOI]
- Chitturi Suryaprakash RT, "Three-dimensional cell culture models to investigate oral carcinogenesis : a scoping review", Int J Mol Sci, 21, pp.9520~ (2020)[DOI]
- Wensink GE, "Patient-derived organoids as a predictive biomarker for treatment response in cancer patients", NPJ Precis Oncol, 5, pp.30~ (2021)[DOI]
- Kang MJ, "Cancer statistics in Korea : incidence, mortality, survival, and prevalence in 2020", Cancer Res Treat, 55, pp.385~399 (2023)[DOI]
- Konishi H, "Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice", Anticancer Res, 29, pp.2091~2097 (2009)
- Feng J, "Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer", Onco Targets Ther, 9, pp.5371~5381 (2016)[DOI]
- Wei H, "Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex", Cancer Sci, 108, pp.478~487 (2017)[DOI]
- Liao T, "Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1", 2 signaling pathway, 2018, pp.9, 1329~1336
- Wei C, "Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation", BMC Cancer, 20, pp.1042~ (2020)[DOI]
- Liu K, "Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1", J Cancer, 10, pp.4196~4207 (2019)[DOI]
- Kalluri R, "Fibroblasts in cancer", Nat Rev Cancer, 6, pp.392~401 (2006)[DOI]